How Immunotherapy Is Changing Mesothelioma Treatment

Immunotherapy is revolutionizing the way mesothelioma is treated. For decades, patients relied mainly on chemotherapy, surgery, and radiation — treatments that sometimes slowed cancer growth but rarely produced long-term survival benefits. Today, immune-checkpoint inhibitors and other advanced immunotherapies are helping patients live longer by teaching the body’s own immune system to recognize and attack cancer cells.

If you or a loved one has been diagnosed with mesothelioma, call 800.291.0963 to learn whether immunotherapy may be an option for your case.

🧬 Step 1: Understand What Immunotherapy Is

Immunotherapy strengthens the immune system’s natural ability to fight cancer.
Cancer cells often hide from immune cells by using “shielding” proteins on their surface. Immune-checkpoint inhibitors disable these shields, allowing the immune system to recognize the cancer as a threat and attack it.

📌 Why Immunotherapy Matters for Mesothelioma

• Mesothelioma tumors often disguise themselves from immune detection

• Traditional treatments do not target cancer “immune evasion”

• Immunotherapy may work even when chemotherapy fails

• It offers treatment options for late-stage patients

• It can be combined with surgery or chemotherapy for better results

Immunotherapy represents one of the first major breakthroughs in mesothelioma treatment in decades.

🛡️ Step 2: How Immune-Checkpoint Inhibitors Work

Cancer cells use proteins called checkpoints to suppress the immune response.
The most important checkpoints in mesothelioma are:

• PD-1 (Programmed Death Receptor)

• PD-L1 (Programmed Death Ligand)

• CTLA-4 (Cytotoxic T-Lymphocyte–Associated Antigen 4)

🧠 How Treatment Helps

Immune-checkpoint inhibitors:

• Block PD-1 or PD-L1

• Prevent cancer cells from “turning off” T-cells

• Reactivate the immune system

• Allow T-cells to attack mesothelioma cells more aggressively

This boosts survival and gives patients new hope.

💉 Step 3: FDA-Approved Immunotherapy for Mesothelioma

In 2020, the FDA approved a combination of two immune-checkpoint inhibitors — a historic first for mesothelioma.

✔ Key Treatments

1. Nivolumab (Opdivo) + Ipilimumab (Yervoy)

• First FDA-approved immunotherapy combo for pleural mesothelioma

• Helps T-cells stay active and destroy cancer cells

• Widely used for patients who are not candidates for surgery

2. Pembrolizumab (Keytruda)

• Approved for cancers expressing high PD-L1

• Showing strong results in many mesothelioma patients

• Often used after chemotherapy stops working

These therapies extend survival and can shrink tumors in ways traditional chemotherapy cannot.

📈 Step 4: How Immunotherapy Improves Survival

While results vary by patient, clinical trials show:

• Longer median survival for many patients

• Improved response rates

• Better quality of life

• Longer periods of disease stability

• Significant benefits for sarcomatoid and biphasic cell types

Sarcomatoid mesothelioma — historically the hardest-to-treat — responds particularly well to immunotherapy.

🧪 Step 5: Immunotherapy Works Best With Biomarker Testing

Before beginning treatment, specialists often test tumor tissue for biomarkers.

📌 Important Biomarkers

• PD-L1 expression

• BAP1 mutation

• Tumor mutation burden (TMB)

• p16 deletion (FISH testing)

💡 Why Biomarkers Matter

• Predict response to immunotherapy

• Help doctors choose the right drug

• Identify clinical trial options

• Guide personalized treatment plans

Not all patients need biomarker testing, but it is increasingly common at top centers.

🧠 Step 6: What to Expect During Immunotherapy Treatment

Immunotherapy is usually given through an IV infusion.

⏱️ Treatment Timeline

• Infusions every 2–3 weeks

• Treatment cycles last up to 2 years

• Regular scans monitor tumor response

• Treatment may continue as long as cancer remains stable

🩺 Monitoring Includes

• Blood tests

• CT or PET-CT scans

• Symptom evaluation

• Immune-related side effect tracking

Patients often tolerate immunotherapy better than traditional chemotherapy.

⚠️ Step 7: Possible Side Effects of Immunotherapy

Because immunotherapy activates the immune system, side effects often involve inflammation.

🛑 Most Common Side Effects

• Fatigue

• Skin rash

• Loss of appetite

• Diarrhea

• Shortness of breath

• Joint pain

🚨 More Serious (but treatable) Side Effects

• Pneumonitis

• Colitis

• Liver inflammation

• Endocrine gland inflammation

Early reporting of symptoms allows doctors to manage side effects quickly.

🔬 Step 8: Combination Treatments Offer Even Better Results

Researchers are combining immunotherapy with other treatments to improve outcomes.

🧬 Promising Combinations

• Immunotherapy + chemotherapy

• Immunotherapy + radiation therapy

• Immunotherapy + surgery (P/D or EPP)

• Immunotherapy + tumor-treating fields (TTF)

• Dual immunotherapy (PD-1 + CTLA-4 inhibitors)

These combinations may help shrink tumors more effectively and extend survival.

🧭 Step 9: Who Is a Good Candidate for Immunotherapy?

Many mesothelioma patients qualify — even those with advanced or unresectable disease.

✔ Ideal Candidates Often Include:

• Patients who aren’t eligible for surgery

• Patients with sarcomatoid or biphasic mesothelioma

• Patients who did not respond to chemotherapy

• Patients with high PD-L1 expression

• Individuals seeking less toxic treatment options

• Patients interested in clinical trials

Even patients with epithelioid mesothelioma benefit in many cases.

🧑‍⚕️ Step 10: Clinical Trials Are Expanding Treatment Possibilities

Ongoing research is developing:

• CAR-T cell therapy

• Mesothelioma cancer vaccines

• Tumor infiltrating lymphocyte therapy (TIL)

• Novel immune-targeting agents

• Personalized immunotherapy based on gene profiling

📌 Why Trials Matter

• Access to cutting-edge therapies

• Some treatments work better than approved drugs

• Extended survival possibilities

• Options for late-stage patients

Your oncologist or specialist can help determine eligibility.

👨‍✈️ Step 11: Why Veterans Especially Benefit From Immunotherapy

Navy veterans and shipyard workers face some of the highest rates of mesothelioma due to heavy asbestos exposure.

✔ Immunotherapy Helps Veterans By:

• Offering options for late-stage disease

• Providing treatment even when surgery isn’t possible

• Working well against aggressive cell types

• Offering access through VA centers with immunotherapy programs

Veterans should request evaluation from a VA oncologist familiar with mesothelioma.

🏥 Where to Get Help

If you or someone you love has mesothelioma, immunotherapy may provide a powerful treatment option.

We help individuals:

• Find oncologists offering the newest immunotherapies

• Access clinical trials at leading cancer centers

• Review biomarker test results

• Understand treatment timelines and side effects

• Connect with VA providers for veteran benefits

• Explore compensation options to help cover treatment costs

📞 Call 800.291.0963 today to learn whether immunotherapy is an option for you and to locate specialists near you.

📝 Summary

Immunotherapy is transforming mesothelioma treatment by:

• Activating the immune system

• Blocking cancer cell “shielding” mechanisms

• Improving survival rates

• Offering treatment for aggressive and late-stage disease

• Providing new options through clinical trials

• Helping patients live longer with fewer side effects

Immune-checkpoint inhibitors have changed the future of mesothelioma care — offering hope where few options once existed.

Take the next step.
📞 Call 800.291.0963 today for immunotherapy guidance and specialist referrals.